Prof. Peng-Sheng Zheng | Medicine and Health Sciences | Professor at Xi’an Jiaotong University | China
Prof. Peng-Sheng Zheng is a distinguished Professor at Xi’an Jiaotong University and an internationally recognized physician-scientist whose career seamlessly integrates advanced medical training, translational research excellence, and global academic leadership. Prof. Peng-Sheng Zheng earned dual M.D./Ph.D. degrees from Bethune Medical University in China and Saga Medical University in Japan, establishing a strong interdisciplinary foundation in clinical medicine and biomedical research. Following doctoral training, Prof. Peng-Sheng Zheng completed prestigious postdoctoral fellowships at Memorial University of Newfoundland in Canada, the U.S. National Institutes of Health (NIH), and the University of Toronto, where he refined expertise in molecular pathology, reproductive immunology, and cancer biology. Prof. Peng-Sheng Zheng has since built an influential academic career marked by sustained research productivity, mentoring, and international collaboration.
Citation Metrics (Scopus)
4000
3000
2000
1000
500
0
🟦 Citations 🟥 Documents 🟩 h-index
View Scopus Profile
Featured Publications
GDF15 deficiency hinders human trophoblast invasion to mediate pregnancy loss through downregulating Smad1/5 phosphorylation
– iScience, 2023
Reproductive effect by rheumatoid arthritis and related autoantibodies
– Review Article
Mechanism of chromosomal mosaicism in preimplantation embryos and its effect on embryo development
– Review Article
Strategies and challenges of mesenchymal stem cells-derived extracellular vesicles in infertility
– Review Article
Exploring the impact of estrogenic endocrine disruptors on cervical cancer progression: A transcriptome analysis and prognostic model development
– Ecotoxicology and Environmental Safety, 2024
ZNF281 facilitates the invasion of cervical cancer cells both in vivo and in vitro
– Cancers, 2024
Correction to: Absence of EpCAM in cervical cancer cells is involved in slug-induced epithelial–mesenchymal transition
– Cancer Cell International, 2021